Profiling of LINS01 compounds at human dopamine D2 and D3 receptors

被引：0
|
作者：
Michelle F Corrêa
David Reiner
Gustavo A B Fernandes
Marina T Varela
Cecília M S Q Aranha
Holger Stark
João Paulo S Fernandes
机构：
[1] Universidade Federal de São Paulo,Department of Pharmaceutical Sciences
[2] Institute of Pharmaceutical and Medicinal Chemistry,undefined
[3] Heinrich Heine University Düsseldorf,undefined
来源：
Journal of Chemical Sciences | 2020年 / 132卷
关键词：
Antihistamine; dopamine receptor ligand; D2 receptor; D3 receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Pramipexole given repeatedly increases responsiveness of dopamine D2 and D3 receptors
    Maj, J
    Dziedzicka-Wasylewska, M
    Rogóz, Z
    Skuza, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R59 - R59
  • [32] Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors
    Thomas, Trayder
    Fang, Yu
    Yuriev, Elizabeth
    Chalmers, David K.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (02) : 308 - 321
  • [33] In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors
    Tadori, Yoshihiro
    Forbes, Robert A.
    McQuade, Robert D.
    Kikuchi, Tetsuro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 668 (03) : 355 - 365
  • [34] Advances and challenges in the search for D2 and D3 dopamine receptor selective compounds
    Moritz, Amy E.
    Free, R. Benjamin
    Sibley, David R.
    CELLULAR SIGNALLING, 2017, 41 : 75 - 81
  • [35] Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors:: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist
    Burstein, ES
    Ma, J
    Wong, S
    Gao, Y
    Pham, E
    Knapp, AE
    Nash, NR
    Olsson, R
    Davis, RE
    Hacksell, U
    Weiner, DM
    Brann, MR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 1278 - 1287
  • [36] Regulation of human D1, D2(long), D2(short), D3 and D4 dopamine receptors by amiloride and amiloride analogues
    Hoare, SRJ
    Coldwell, MC
    Armstrong, D
    Strange, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) : 1045 - 1059
  • [37] The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
    Wicke, K
    Garcia-Ladona, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (02) : 85 - 90
  • [38] Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H1, H2, and H3 receptors
    Correa, Michelle Fidelis
    Ramos Barbosa, Alefe Jhonatas
    Borges Fernandes, Gustavo Ariel
    Baker, Jillian G.
    dos Santos Fernandes, Joao Paulo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (01) : 89 - 95
  • [39] Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets:: Mediation by D2, not D3, dopamine receptors
    Hill, Michael P.
    Ravenscroft, Paula
    McGuire, Steven G.
    Brotchie, Jonathan M.
    Crossman, Alan R.
    Rochat, Catherine
    Millan, Mark J.
    MOVEMENT DISORDERS, 2006, 21 (12) : 2090 - 2095
  • [40] Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia
    Ohara, K
    Nakamura, Y
    Xie, DW
    Ishigaki, T
    Deng, ZL
    Tani, K
    Zhang, HY
    Kondo, N
    Liu, JC
    Miyasato, K
    Ohara, K
    BIOLOGICAL PSYCHIATRY, 1996, 40 (12) : 1209 - 1217
12345